PA-20-072, Measuring the Clinical and Economic Outcomes Associated with Delivery Systems: "Are Health Systems Better at Responding to Pandemics?"
PA-20-072, Measuring the Clinical and Economic Outcomes Associated with Delivery Systems: "Are Health Systems Better at Responding to Pandemics?"
批准号:
10175812
负责人:
DAVID M CUTLER
金额:
$234.87万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-01 至 2022-12-14
中文摘要
其他项目信息-项目概要/摘要
PA-20-072:卫生系统是否更好地应对流行病?
这个项目的目标是提供证据证明综合卫生系统是否会带来更好或更差的护理
在COVID-19疫情期间,独立供应商的结果。医疗保健经历了巨大的
近年来,随着供应商迅速组装成更大的系统,合并也越来越多。从业者和政策
制造商们就这种整合是好是坏展开了激烈的辩论,
只有一点经验证据
我们将研究综合护理在一个至关重要的背景下的影响-应对COVID-19
疫情在流行病期间,综合护理系统具有一些优势:它们可能具有财政上的优势,
资源,以更好地抵御负面的收入冲击,更多的物理空间,以分开COVID-19和非
COVID-19患者,以及更好的信息技术基础设施,以允许大规模的远程医疗。然而,在这方面,
综合系统可能过于集中于急性病人,以至于无法跟上基于社区的
需要的人口。大型综合系统也可能与每个患者的需求联系较少。
我们提出的分析有三个组成部分。首先,我们将研究如何不同的药物治疗的病人
在COVID-19危机期间,在综合卫生系统内外。治疗措施将包括检测
对于COVID-19以及COVID-19的医疗护理接收:与医疗保健提供者的访问(无论是亲自
和远程医疗),并为社区中的人提供长期治疗。第二,我们将研究
系统内外患者的健康结果和护理体验如何不同。某个结果
措施适用于许多患者群体,包括死亡、严重疾病住院治疗,
患者对所接受护理质量的评估。其他结果是特定于某些亚组,包括
癌症患者的肿瘤进展,妊娠患者分娩部位的变化,以及生存能力
为有身体和精神障碍的成人和儿童独立提供服务。第三,我们将研究
由于COVID-19,护理组织正在发生变化。为了理解这一点,我们将跟踪实践关闭
沿着的是随着COVID-19疫情的发展,较小的供应商合并成较大的系统。
我们的患者分析将使用几个数据来源,包括医疗保险索赔,商业索赔记录,
有保险的个人,以及在大州分娩的人。为了跟踪关闭,我们将使用Medicare付款
沿着私营部门关于保健整合的数据。
英文摘要
OTHER PROJECT INFORMATION – Project Summary/Abstract
PA-20-072: Are Health Systems Better at Responding to Pandemics?
The goal of this project is to provide evidence on whether integrated health systems lead to better or worse care
outcomes than independent providers during the COVID-19 epidemic. Health care has undergone enormous
consolidation in recent years, as providers have rapidly assembled into bigger systems. Practitioners and policy
makers have engaged in spirited debate about whether such consolidation is good or bad, but there has been
only a little empirical evidence on the topic.
We will study the impact of integrated care in a crucially important setting – the response to the COVID-19
epidemic. Integrated systems of care have some advantages during an epidemic: they may have the financial
resources to better withstand negative revenue shocks, more physical space to separate COVID-19 and non-
COVID-19 patients, and better information technology infrastructure to permit widescale telemedicine. However,
integrated systems may be so focused on acute patients that they fail to keep up with the community-based
population in need. Large integrated systems may also be less in touch with the needs of each individual patient.
Our proposed analysis has three components. First, we will examine how medical treatments differ for patients
in and outside of integrated health systems during the COVID-19 crisis. Measures of treatment will include testing
for COVID-19 as well as medical care receipt apart of COVID-19: visits with health care providers (both in-person
and telemedicine), and maintenance of chronic therapy for those in the community. Second, we will examine
how health outcomes and the experience of care differ for patients in and outside of systems. Some outcome
measures are appropriate for many groups of patients, including death, hospitalization with severe disease, and
patient assessments of the quality of care received. Other outcomes are specific to certain subgroups, including
tumor progression for patients with cancer, changes in site of delivery for pregnant patients, and ability to live
independently for adults and children with physical and mental impairments. Third, we will examine how the
organization of care is changing as a result of COVID-19. To understand this, we will track practice closures
along with mergers of smaller providers into larger systems as the COVID-19 epidemic proceeds.
Our patient analysis will use several sources of data, including Medicare claims, claims records for commercially
insured individuals, and people giving birth in a large state. To track closures, we will use Medicare payment
data along with private sector data on health care consolidation.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Demographic And Clinical Factors Associated With Long COVID.
与长期新冠病毒相关的人口统计和临床因素。
DOI:
10.1377/hlthaff.2022.00991
发表时间:
2023
期刊:
Health affairs (Project Hope)
影响因子:
--
作者:
[Song,Zirui, Giuriato,Mia]
通讯作者:
Giuriato,Mia
Adoption of Innovative Therapies Across Oncology Practices-Evidence From Immunotherapy.
在肿瘤学实践中采用创新疗法——来自免疫疗法的证据。
DOI:
10.1001/jamaoncol.2022.6296
发表时间:
2023
期刊:
JAMA oncology
影响因子:
28.4
作者:
[Carroll,CaitlinE, Landrum,MaryBeth, Wright,AlexiA, Keating,NancyL]
通讯作者:
Keating,NancyL
Reply to W. E. Rosa et al and T. N. Townsend et al.
回复 W. E. Rosa 等人和 T.N. Townsend 等人。
DOI:
10.1200/jco.21.02383
发表时间:
2022
期刊:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
影响因子:
--
作者:
[Enzinger,AndreaC, Ghosh,Kaushik, Keating,NancyL, Cutler,DavidM, Landrum,MaryBeth, Wright,AlexiA]
通讯作者:
Wright,AlexiA
DOI:
10.1001/jamahealthforum.2021.4223
发表时间:
2021-12
期刊:
JAMA health forum
影响因子:
--
作者:
[Song Z, Zhang X, Patterson LJ, Barnes CL, Haas DA]
通讯作者:
Haas DA
Producing comparable cost and quality results from all-payer claims databases.
从所有付款人索赔数据库中生成可比较的成本和质量结果。
DOI:
--
发表时间:
2019
期刊:
The American journal of managed care
影响因子:
--
作者:
[Diaz-Perez,MariadeJesus, Hanover,Rita, Sites,Emilie, Rupp,Doug, Courtemanche,Jim, Levi,Emily]
通讯作者:
Levi,Emily
共 6 条
Constructing U.S. Life Tables by Educational Status, 1990-2011
-
批准号:9110621
-
项目类别:
-
资助金额:$8.19万
-
财政年份:2016
-
负责人:DAVID M CUTLER
-
依托单位:
Constructing U.S. Life Tables by Educational Status, 1990-2011
-
批准号:9326122
-
项目类别:
-
资助金额:$8.21万
-
财政年份:2016
-
负责人:DAVID M CUTLER
-
依托单位:
Using Satellite National Health Accounts to Understand Health and Cost Changes
-
批准号:10397148
-
项目类别:
-
资助金额:$72.5万
-
财政年份:2015
-
负责人:DAVID M CUTLER
-
依托单位:
Using Satellite National Health Accounts to Understand Health and Cost Changes
-
批准号:10239258
-
项目类别:
-
资助金额:$72.5万
-
财政年份:2015
-
负责人:DAVID M CUTLER
-
依托单位:
Measuring the Clinical and Economic Outcomes Associated with Delivery Systems
-
批准号:8955131
-
项目类别:
-
资助金额:$349.21万
-
财政年份:2015
-
负责人:DAVID M CUTLER
-
依托单位:
Using Satellite National Health Accounts to Understand Health and Cost Changes
-
批准号:9258376
-
项目类别:
-
资助金额:$62.5万
-
财政年份:2015
-
负责人:DAVID M CUTLER
-
依托单位:
Measuring the Clinical and Economic Outcomes Associated with Delivery Systems
-
批准号:9769626
-
项目类别:
-
资助金额:$349.21万
-
财政年份:2015
-
负责人:DAVID M CUTLER
-
依托单位:
Measuring the Clinical and Economic Outcomes Associated with Delivery Systems
-
批准号:9341182
-
项目类别:
-
资助金额:$349.21万
-
财政年份:2015
-
负责人:DAVID M CUTLER
-
依托单位:
International Research Network on Valuing Health Research
-
批准号:8756107
-
项目类别:
-
资助金额:$14.07万
-
财政年份:2014
-
负责人:DAVID M CUTLER
-
依托单位:
International Research Network on Valuing Health Research
-
批准号:9116071
-
项目类别:
-
资助金额:$14.07万
-
财政年份:2014
-
负责人:DAVID M CUTLER
-
依托单位:
Expanding the National Health Accounts
-
批准号:7560487
-
项目类别:
-
资助金额:$182.32万
-
财政年份:2009
-
负责人:DAVID M CUTLER
-
依托单位:
Expanding the National Health Accounts
-
批准号:7759610
-
项目类别:
-
资助金额:$187.78万
-
财政年份:2009
-
负责人:DAVID M CUTLER
-
依托单位:
Expanding the National Health Accounts
-
批准号:8423010
-
项目类别:
-
资助金额:$174.09万
-
财政年份:2009
-
负责人:DAVID M CUTLER
-
依托单位:
Expanding the National Health Accounts
-
批准号:8223266
-
项目类别:
-
资助金额:$185.02万
-
财政年份:2009
-
负责人:DAVID M CUTLER
-
依托单位:
Expanding the National Health Accounts
-
批准号:8050103
-
项目类别:
-
资助金额:$186.82万
-
财政年份:2009
-
负责人:DAVID M CUTLER
-
依托单位:
A Pilot Survey to Measure Disability in the Elderly Population
-
批准号:7140635
-
项目类别:
-
资助金额:$9.47万
-
财政年份:2005
-
负责人:DAVID M CUTLER
-
依托单位:
A Pilot Survey to Measure Disability in the Elderly Population
-
批准号:7019561
-
项目类别:
-
资助金额:$20.42万
-
财政年份:2005
-
负责人:DAVID M CUTLER
-
依托单位:
EXPLAINING HEALTH DECISION-MAKING
-
批准号:6740567
-
项目类别:
-
资助金额:$21.45万
-
财政年份:2004
-
负责人:DAVID M CUTLER
-
依托单位:
ACCESS TO MEDICAL CARE
-
批准号:6666212
-
项目类别:
-
资助金额:$17.85万
-
财政年份:2002
-
负责人:DAVID M CUTLER
-
依托单位:
ACCESS TO MEDICAL CARE
-
批准号:6563274
-
项目类别:
-
资助金额:$17.85万
-
财政年份:2002
-
负责人:DAVID M CUTLER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CDC20-HDAC6-POLD1轴调控肺腺癌免疫微环境的机制研究
-
批准号:2026JJ80369
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:胡智
-
依托单位:
CCL20/CCR6/SEMA3C信号轴通过EMT及肿瘤干细胞互作调控阴茎癌转移的分子机制研究
-
批准号:2026JJ50313
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:胡希恒
-
依托单位:
USP20调控泛素化修饰介导微卫星稳定型结直肠癌免疫逃逸的机制研究
-
批准号:JCZRLH202600106
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
巴多昔芬通过重编程肿瘤相关巨噬细胞抑制CCL20介导的Treg募集并增敏乳腺癌免疫治疗的机制研究
-
批准号:JCZRQNB202600315
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
IFT20 抑制肝星状细胞活化并诱导其凋亡的机制研究
-
批准号:2026JJ82074
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:金富昌
-
依托单位:
新型可降解聚酯P20-2C联合利福平根除关节假体表面细菌生物膜的机制与应用研究
-
批准号:2026JJ82609
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱怡
-
依托单位:
CL-20共晶/Al纳米复合炸药热分解-燃烧反应机理研究
-
批准号:JCZRLH202601722
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
SFRT激活新型STING调控因子协同CD3/CD20双抗治疗RR DLBCL的机制研究
-
批准号:JCZRLH202600672
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
亚20nm FinFET工艺下SRAM单粒子翻转机制及抗辐照加固关键技术研究
-
批准号:2026JJ60232
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:喻国芳
-
依托单位:
合肥长安燃油泵及支架总成1106100-DS20的研发及应用
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:冯国雄
-
依托单位: